Chemed (Chemed) Risk Assessment

View and export this data going back to 1982. Start your Free Trial

What is Chemed Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Chemed is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Chemed's Risk Assessment

For the Medical Care Facilities subindustry, Chemed's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chemed's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chemed's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Chemed's Risk Assessment falls into.

Chemed (NYSE:CHE) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Chemed Risk Assessment Related Terms

Thank you for viewing the detailed overview of Chemed's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemed (Chemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chemed Corp (NYSE:CHE) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

CXM:Germany

Address

255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726

Website

https://www.chemed.com

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.

Executives

Kevin J Mcnamara	director, officer: president & ceo	2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
Spencer S Lee	officer: vice president	2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
David Patrick Williams	officer: Vice President & CFO
Nicholas Michael Westfall	officer: Executive Vice President	8035 PEREGRINE LANE, CINCINNATI OH 45243
Patrick P Grace	director	1100 PARK AVE, APT 15C, NEW YORK NY 10128
Eileen P Mccarthy	director	3515 78TH STREET, #2, JACKSON HEIGHTS NY 11372
Michael D Witzeman	officer: vice president and controller	255 E 5TH STREET, SUITE 2600, CINCINNATI OH 45202
Mount John Meredith Jr.	director	2906 MABRY ROAD NE, ATLANTA GA 30319
Donald E Saunders	director	306 MIANI TRAIL, OXFORD OH 45056
Christopher J Heaney	director	101 S. FORT LAUDERDALE BEACH BLVD., APARTMENT 1602, FORT LAUDERDALE FL 33316
Ron Delyons	director	2692 MADISON ROAD, SUITE N1-313, CINCINNATI OH 45208
Naomi C Dallob	officer: VP and Chief Legal Officer	255 EAST FIFTH STREET, SUITE 2600, CINCINNATI OH 45202
Thomas C Hutton	director, officer: vice president	ONE ROCKEFELLER PLAZA, STE 1510, NEW YORK NY 10020
Walsh George J Iii	director	ONE CHASE MANHATTAN PLAZA, NEW YORK NY 10005
Andrea R Lindell	director